Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.

Gilbert R. Thompson, J. Philip Miller, Jan L. Breslow

BMJ · 1985 · 221 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

Plasma exchange was undertaken in five patients with homozygous familial hypercholesterolaemia at intervals of two weeks for a mean of 8.4 years. These patients had survived an average of 5.5 years longer than their five respective homozygous siblings (p = 0.3), each of whom must have had a matching genetic defect but who died untreated. The 37% decrease in peak serum cholesterol concentrations maintained by plasma exchange presumably reduced progression of atherosclerosis in the treated patients and thus lessened their risk of premature death.

References

31